This study aimed to investigate how structural analogs of TU and DA interact with key molecular targets (voltage‐dependent anion channel 1 [VDAC1], PHB, and matrix metalloproteinase [MMP]9), while also considering their bioavailability of their potential to modulate CRC development. This evidence concerns the gene PHB1 and colorectal carcinoma.